HOPE-2 Study (Heart Outcomes Prevention Evaluation-2 Study)
Status:
Unknown status
Trial end date:
2005-10-01
Target enrollment:
Participant gender:
Summary
The purpose of the HOPE-2 study is to determine whether long term supplementation with folic
acid, vitamins B6 and B12 aimed at homocyst(e)ine reduction reduces the rates of major fatal
and nonfatal cardiovascular events in patients with established cardiovascular disease and/or
diabetes mellitus.
Phase:
Phase 4
Details
Lead Sponsor:
Hamilton Health Sciences Corporation
Collaborators:
Canadian Institutes of Health Research (CIHR) Population Health Research Institute
Treatments:
Folic Acid Pyridoxal Pyridoxine Vitamin B 6 Vitamin B Complex Vitamins